Skip to main content
Journal ArticleOPEN ACCESS

Successful treatment of adult-onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis

Clinical Case Reports (2021) 9(1) 278-281
DOI: 10.1002/ccr3.3514
4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Octreotide may be useful in noninsulinoma pancreatogenous hypoglycemia syndrome with nesidioblastosis patients who was on hemodialysis. Continuous octreotide subcutaneous infusion can reduce side-effects and stabilize plasma glucose levels.

Author supplied keywords

Cite

CITATION STYLE

APA

Kato, R., Nishimura, A., Matsumura, K., Kikuno, S., Nagasawa, K., & Mori, Y. (2021). Successful treatment of adult-onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis. Clinical Case Reports, 9(1), 278–281. https://doi.org/10.1002/ccr3.3514

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free